Company intelligence / Profile preview

Intavis

Tübingen, Baden-Württemberg, Germanyintavispeptides.com ↗

Ownership: Private
Development stage: Commercial

Overview

Intavis Peptide Services is a leading European provider of custom peptide synthesis services with nearly 30 years of experience. The company specializes in GMP-grade peptides for laboratory research and clinical trials—including personalized neoantigen cancer vaccine manufacturing—and offers end-to-end CDMO services from early R&D through fill & finish. Their products are widely used in academic research, preclinical studies, and increasingly in clinical settings supporting precision medicine initiatives.

Therapeutic areas: Oncology
Modalities: Synthetic peptidesPeptide nucleic acids (PNA)Neoantigen peptide vaccines
Industry: Contract Manufacturing Organization

Partnerships

Collaborates with global biotech/pharma companies and academic groups worldwide [5]

Beyond the preview

Go deeper on Intavis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intavis.

Explore the full profile